Results 141 to 150 of about 664,100 (294)
A peculiar case of primary lymphoma of pancreas: A rare presentation of Hodgkin lymphoma. [PDF]
Mohiuddin O +5 more
europepmc +1 more source
B‐cell lymphomas are aggressive malignancies with limited treatment options. A bispecific nanosystem (biHSNPs) is developed, leveraging silica nanoplatforms to conjugate antibodies targeting immune effector cells and B‐cell antigens. biHSNPs form artificial immunological synapses, activating cytotoxic responses and suppressing tumor proliferation. This
Yefeng Shen +12 more
wiley +1 more source
Tissue-Equivalents of Lymphoid Clonal Hematopoiesis of Indeterminate Potential (L-CHIP) and Germline-Derived Lymphoproliferations: Possible Caveats for Hematopathologists. [PDF]
Brune MM +3 more
europepmc +1 more source
The model shows the probiotics screening and underlying mechanisms of F. rodentiumn in alleviating IR‐induced tissue injury. Stress‐induced STAT3 mitochondria localization decreases F. rodentium abundance and butyrate concentration. Supplementation of F.
Hanyong Zhu +17 more
wiley +1 more source
Dihydrofolate Reductase from a Resistant Subline of the L1210 Lymphoma
John P. Perkins +2 more
openalex +1 more source
Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression. [PDF]
Shao L +6 more
europepmc +1 more source
Ischemic stroke is a serious disease with high rates of mortality and disability, but there is a lack of novel therapeutic targets and agents for it. Now it is shown that Ras GTPase‐activating protein SH3 domain‐binding protein 1 (G3BP1) has the potential to serve as a therapeutic target for ischemic stroke.
Heyanhao Zhang +10 more
wiley +1 more source

